구조적 심장 영상 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 수술별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Structural Heart Imaging Market Growth & Trends:

The global structural heart imaging market size is expected to reach USD 13.12 billion by 2030, registering a CAGR of 5.92%, according to a new report by Grand View Research, Inc. Global increase in incidence of Structural Heart Diseases (SHDs), growing awareness about diseases, and technological advancements in imaging modalities are anticipated to drive the market during the forecast period.

Furthermore, clearer high-quality images are necessary for management of patients suffering from SHDs. Hence, availability of technologically advanced devices and increase in their adoption are likely to boost the market in the coming years. Echocardiogram, Magnetic Resonance Imaging (MRI) and CT are the most widely used modalities for SHI.

Echocardiogram accounted for the maximum market share in 2023 and is estimated to maintain its dominance during the forecast period. This can be attributed to the adoption of echo test as a first-line imaging technique, low cost as compared to CT & MRI, and its superiority in visualization of intracardiac structures.

MRI segment is expected to witness the fastest growth in the coming years due to technological advancements, as well as the ability of MRI to provide accurate & reproducible quantification of ventricular function and image the entire body.

Structural Heart Imaging Market Report Highlights:

• The angiogram accounted as the most dominant segment with a share of 36.75% in 2024. During angiography, the devices detect heart failures and other cardiovascular diseases.
• The Transcatheter Aortic Valve Replacement (TAVR) segment dominated by capturing the market share of 22.58% in 2024, driven by its widespread adoption as a minimally invasive alternative to open-heart surgery for treating aortic stenosis.
• Geographically, in 2024, North America accounted the largest share and is expected to maintain its dominance during forecast period due to availability of technologically advanced devices, high healthcare expenditure, and favorable reimbursement policies for imaging
• Asia Pacific is likely to witness lucrative growth in the coming years owing to growing investments by players in the region and increase in well-equipped & sophisticated hospitals. These factors are expected to result in rise in demand for advanced procedures for structural heart diseases

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Procedure
  • 1.2.3. Application
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Procedure mode outlook
  • 2.2.3. Application outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Structural Heart Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of cardiac diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing adoption of minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced imaging systems
    • 3.2.2.2. Stringent regulatory approvals
• 3.3. Structural Heart Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Structural Heart Imaging Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Medical Digital Imaging System Modality Market Movement Analysis
• 4.3. Global Structural Heart Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 4.4. Echocardiogram
  • 4.4.1. Echocardiogram market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Angiogram
  • 4.5.1. Angiogram market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. CT
  • 4.6.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. MRI
  • 4.7.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Nuclear Imaging
  • 4.8.1. Nuclear Imaging market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Other Modalities
  • 4.9.1. Other Modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Structural Heart Imaging Market: Procedure Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Medical Digital Imaging System Procedure Market Movement Analysis
• 5.3. Global Structural Heart Imaging Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
• 5.4. Transcatheter Aortic Valve Replacement (TAVR)
  • 5.4.1. Transcatheter Aortic Valve Replacement (TAVR) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Surgical Aortic Valve Replacement (SAVR)
  • 5.5.1. Surgical Aortic Valve Replacement (SAVR) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Transcatheter Mitral Valve Repair (TMVR)
  • 5.6.1. Transcatheter Mitral Valve Repair (TMVR) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Left Atrial Appendage Closure (LAAC)
  • 5.7.1. Left Atrial Appendage Closure (LAAC) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Tricuspid Valve Replacement and Repair
  • 5.8.1. Tricuspid Valve Replacement and Repair market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Paravalvular Leak Detection and Repair
  • 5.9.1. Paravalvular Leak Detection and Repair market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Annuloplasty
  • 5.10.1. Annuloplasty market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Valvuloplasty
  • 5.11.1. Valvuloplasty market estimates and forecasts 2018 to 2030 (USD Million)
• 5.12. Other Structural Heart Procedures
  • 5.12.1. Other Structural Heart Procedures market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Structural Heart Imaging Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Medical Digital Imaging System Application Market Movement Analysis
• 6.3. Global Structural Heart Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Diagnostic Imaging
  • 6.4.1. Diagnostic Imaging market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Interventional Cardiology
  • 6.5.1. Interventional Cardiology market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Structural Heart Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Medical Digital Imaging System End Use Market Movement Analysis
• 7.3. Global Structural Heart Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Ambulatory Surgical Centers
  • 7.5.1. Ambulatory Surgical Centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Diagnostic Imaging Centers
  • 7.6.1. Diagnostic Imaging Centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Other End Use
  • 7.7.1. Other End Use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Structural Heart Imaging Market: Regional Estimates & Trend Analysis By Modality, Procedure, Application, End Use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement structure
    • 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • . Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2024
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. Siemens Healthineers
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Product benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. GE Healthcare
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Product benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. Koninklijke Philips N.V.
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Product benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Canon Medical Systems
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Product benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Fujifilm Holdings Corporation
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Product benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. Shanghai United Imaging Healthcare Co., LTD
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Product benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Abbott
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Product benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Terumo Corporation
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Product benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Samsung Medison Co., Ltd.
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Product benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. Lepu Medical Technology
    • 9.6.10.1. Company overview
    • 9.6.10.2. Financial performance
    • 9.6.10.3. Product benchmarking
    • 9.6.10.4. Strategic initiatives